Company intelligence / Profile preview

Eubiogen

Warsaw, Poland

Ownership: Private
Development stage: Commercial

Overview

Eubiogen is a Polish company established in January 2023, primarily engaged in scientific research and experimental development on biotechnology. The company also provides services related to food quality testing, market research, non-school education/training, physiotherapy activities, software services, and other human health activities. There are no public records of clinical results or advanced drug pipeline as of the latest update.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Eubiogen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eubiogen.

Explore the full profile